MannKind designates Danbury facility as new corporate headquarters, plans expansion

MannKind Corporation designated its Danbury, Connecticut manufacturing and R&D facility as its new corporate headquarters, adding more than 50 jobs in 2023 and planning further expansions.

“MannKind CEO Michael Castagna cited planned expansions of the Danbury facility and its 'increasing strategic importance' to the company as reasons for the new designation.”bdavison.bloxcms.com

• 1 source
• bdavison.bloxcms.comFour Life Sciences Companies Announce Expansions in Connecticut | | bdavison.bloxcms.comAdvanceCT, MannKind Corporation, Millstone Medical, ReST Therapeutics, Revalia BioDec 19, 2023

Summarized from public sources; check the original articles before acting on it.